Pharmaceuticals, personal care products and endocrine disrupting agents in the environment - A review

Clean - Soil, Air, Water

Volumn 37, Issue 4-5, 2009, Pages 277-303

  Caliman, Florentina Anca ^a   Gavrilescu, Maria ^a  

^a GHEORGHE ASACHI TECHNICAL UNIVERSITY OF IASI   (Romania)

Author keywords

(Bio)degradation; Endocrine disrupting agents; Environmental fate; Personal care products; Pharmaceuticals; Sorption; Wastewater

Indexed keywords

BIODEGRADATION; DRUG; ECOTOXICOLOGY; ENDOCRINE DISRUPTOR; ENVIRONMENTAL FATE; ENVIRONMENTAL IMPACT; SORPTION; WASTEWATER;

EID: 69549131367     PISSN: 18630650     EISSN: None     Source Type: Journal    
DOI: 10.1002/clen.200900038     Document Type: Review

References (165)

1. F. Ingerslev, E. Vaclavik, B. Halling-Sorenses, Pharmaceuticals and Personal Care Products: A Source of Endocrine Disruption in the Environment, Pure Appl. Chem. 2003, 75, 1881.
2. V. L. Cunningham, S. P. Binks, M. J. Olson, Human Health Risk Assessment from the Presence of Human Pharmaceuticals in the Aquatic Environment, Regul. Toxicol. Pharmacol. 2009, 53, 39.
3. I. Munoz et al., Ranking Potential Impacts of Priority and Emerging Pollutants in Urban Wastewater through Life Cycle Impact Assessment, Chemosphere 2008, 74, 37.
4. M. Kotchen et al., Pharmaceuticals in Wastewater: Behavior, Preferences and Willingness to Pay for a Disposal Program, J. Environ. Manage. 2009, 90, 1476.
5. M. Petrovic, E. Eljarrat, M. J. Lopez de Alda, D. Barcelo, Endocrine Disrupting Compounds and Other Emerging Contaminants in the Environment: A Survey on New Monitoring Strategies and Occurrence Data, Anal. Bioanal. Chem. 2004, 378, 549.
6. D. Bendz, N. A. Paxeus, T. R. Ginn, F. J. Loge, Occurrence and Fate of Pharmaceutically Active Compounds in the Environment, A Case Study: Höje River in Sweden, J. Hazard. Mater. 2005, 22, 195.
7. K. Bester, N. Huffmeyer, E. Schaub, J. Klasmeier, Surface Water Concentrations of the Fragrance Compound OTNE in Germany-A Comparison between Data from Measurements and Models, Chemosphere 2008, 73, 1366.
8. B. Kasprzyk-Hordern, R. M. Dinsdale, A. J. Guwy, The Removal of Pharmaceuticals, Personal Care Products, Endocrine Disruptors and Illicit Drugs during Wastewater Treatment and Its Impact on the Quality of Receiving Water, Water Res. 2009, 43, 363.
9. M. Kuster et al., Analysis and Occurrence of Pharmaceuticals, Estrogens, Progestogens and Polar Pesticide in Sewage Treatment Plant Effluents, River Water and Drinking Water in the Llobregat River Basin, J. Hydrol. 2008, 358, 112.
10. S. L. Bartelt-Hunt et al., The Occurrence of Illicit and Therapeutic Pharmaceuticals in Wastewater Effluent and Surface Waters In Nebraska, Environ. Pollut. 2009, 157, 786.
11. X. Zhang et al., Synthetic Musks in the Aquatic Environment and Personal Care Products in Shanghai, China, Chemosphere 2008, 72, 1553.
12. J. L. Zhou et al., Pharmaceuticals Residues in Wastewater Treatment Works Effluents and Their Impact on Receiving River Water, J. Hazard. Mater., in press. DOI 10.1016/j.jhazmat.2008.11.070.
13. A. Sosiak, T. Hebben, A Preliminary Survey of Pharmaceuticals and Endocrine Disrupting Compounds in Treated Municipal Wastewaters and Receiving Rivers of Alberta, Technical Report T/773, Environmental Monitoring and Evaluation Branch, Alberta Environment, Edmonton, Canada 2005.
14. M. J. Focazio et al., A National Reconnaissance of Pharmaceuticals and Other Organic Wastewater Contaminants in The United States-II) Untreated Drinking Water Sources, Sci. Total Environ. 2008, 402, 201.
15. K. K. Barnes et al., A National Reconnaissance of Pharmaceuticals and Other Organic Wastewater Contaminants in the United States: (I) Groundwater, Sci. Total Environ. 2008, 402, 192.
16. P. A. Lara-Martin, A. Gomez-Parra, E. Gonzales-Mazo, Reactivity and Fate of Synthetic Surfactants in Aquatic Environments, Trends Anal. Chem. 2008, 27, 684.
17. P. Pothitou, D. Voutsa, Endocrine Disrupting Compounds in Municipal and Industrial Wastewater Treatment Plants in Northern Greece, Chemosphere 2008, 73, 1716.
18. R. Mauricio et al., A Characterization of Selected Endocrine Disruptor Compounds in a Portuguese Wastewater Treatment Plant, Environ. Monit. Assess. 2006, 118, 75.
19. C. Yapijakis, L. K. Wang, Treatment of Soap and Detergent in Industry Wastes, in Handbook of Industrial and Hazardous Wastes Treatment, (Eds: L. K. Wang, Y-S. Hung, H. H. Lo, C. Yapijakis), Marcel Dekker, New York 2004, 323.
20. N. Casajuana, S. Lacorte, Presence and Release of Phthalic Esters and Other Endocrine Disrupting Compounds in Drinking Water, Chromatographia 2003, 57, 649.
21. R. A. Rudel, L. J. Petrovich, Endocrine Disrupting Chemicals in Indoor and Outdoor Air, Atmos. Environ. 2009, 43, 170.
22. I. R. Falconer, Are Endocrine Disrupting Compounds a Health Risk in Drinking Water? Int. J. Environ. Res. Public Health 2006, 3, 180.
23. S. A. Snyder, Endocrine Disruptors as Water Contaminants: Toxicological Implications for Humans and Wildlife, Southwest Hydrol. 2003, Nov/Dec, 14.
24. Y. Wang et al., Occurrence of Endocrine-Disrupting Compounds in Reclaimed Water from Tianjin, China, Anal. Bioanal. Chem. 2005, 383, 857.
25. J. M. Vogel, Tunnel Vision: The Regulation of Endocrine Disruptors, Policy Sci. 2004, 37, 277.
26. P. Mathiessen, Is Endocrine Disruption a Significant Ecological Issue? Ecotoxicology 2000, 9, 21.
27. S. M. Dickerson, A. C. Gore, Estrogenic Environmental Endocrine-Disrupting Chemical Effects on Reproductive Neuroendocrine Function and Dysfunction across the Life-Cycle, Rev. Endocr. Metab. Disord. 2007, 8, 143.
28. M. E. DeLorenzo, J. Fleming, Individual and Mixture Effects of Selected Pharmaceuticals and Personal Care Products on the Marine Phytoplankton Species Dunaliella terticoleta, Arch. Environ. Contam. Toxicol. 2008, 54, 203.
29. G. Paterson, C. D. Metcalfe, Uptake and Depuration of the Anti-Depressant Fluoxecine by the Japanese Medaka (Oryzias Latipes), Chemosphere 2008, 74, 125.
30. M. S. Diaz-Cruz, M. Llorca, D. Barcelo, Organic UV filters and their Photodegradates, Metabolites, and Disinfection By-products in the Aquatic Environment, Trends Anal. Chem. 2008, 27, 873.
31. C. S. Quan et al., Biodegradation of Endocrine-Disrupting Chemical, Di-ethylhexyl Phthalate, by Bacillus subtilis, Appl. Microbiol. Biotechnol. 2005, 66, 702.
32. Z. Juvancz, S. Barna, D. Gyarmathy, F. Konorot, Study of Endocrine Disrupting Chemicals in the Environment, Acta Polytechnica Hungarica 2008, 5, 49.
33. U. Klaschka, M. Colossa-Gehring, Fragrances in the Environment: Pleasant Odors for Nature? Environ. Sci. Pollut. Res. 2007, 1, 44.
34. Z. Moldovan, R. Chira, A. C. Alder, Occurrence And Behavior of Pharmaceuticals and Musk Fragrances in the Somes River Before and After Upgrading the Municipal WWTP Cluj-Napoca, Danube News-Bulletin Int. Assoc. Danube Research (IAD) 2008, 16, 4.
35. M. Farre, S. Perez, L. Kantiani, D. Barcelo, Fate and Toxicity of Emerging Pollutants, Their Metabolites and Transformation Products in Aquatic Environment, Trends Anal. Chem. 2008, 27, 991.
36. A. Y. C. Lin, T. H. Yu, C. F. Lin, Pharmaceutical Contamination in Residential, Industrial and Agricultural Waste Streams: Risk to Aqueous Environments in Taiwan, Chemosphere 2008, 74, 131.
37. T. Assmuth, K. Louekari, Research for Management of Environmental Risks From Endocrine Disrupters - Contexts, Knowledge Base, Methodologies and Strategies, Finnish Environment Institute, Helsinki 2001.
38. G. A. Mills et al., Trends in Monitoring Pharmaceuticals and Personal-Care Products in the Aquatic Environment by Use of Passive Sampling Devices, Anal. Bioanal. Chem. 2007, 387, 1153.
39. S. L. MacLeod, E. L. McClure, C. S. Wong, Laboratory Calibration and Field Development of Polar Organic Chemical Integrative Sampler for Pharmaceutical and Personal Care Products in Wastewater and Surface Water, Environ. Toxicol. Chem. 2007, 26, 2517.
40. E. Loffredo, N. Senesi, The Role of Humic Substances in the Fate of Anthropogenic Organic Pollutants in Soil with Emphasis on Endocrine Disruptor Compounds, in Soil and Water Pollution Monitoring, Protection and Remediation, (Eds: I. Twardowska, H. E. Allen, M. M. Häggblom, S. Stefaniak), NATO Science Series, Vol. 69, Springer, New York, 2006.
41. E. Means, A. Ghosh, Z. Chowdhury, Endocrine Disruptor and Pharmaceuticals Strategic Initiative, Expert Workshop Report, AwwaRF Project 4142, November 2007.
42. C. G. Daughton, T. A. Ternes, Pharmaceuticals and Personal Care Products in Environment: Agents of Subtle Changes? Environ. Health Perspective 1999, 107, 907.
43. W. L. Sun, J. R. Ni, T. T. Liu, Effect of Sediment Humic Substances on Sorption of Selected Endocrine Disruptors, Water, Air, Soil Pollut. 2006, 6, 583.
44. T. L. Jones-Lepp, R. Stevens, Pharmecuticals and Personal Care Products in Biosolids/Sewage Sludge: The Interface between Analytical Chemistry and Regulation, Anal. Bioanal. Chem. 2007, 387, 1173.
45. S. Suarez, M. Carballa, F. Omil, J. M. Lema, How are Pharmaceutical and Personal Care Compounds Removed from Urban Wastewaters, Rev. Environ. Sci. Biotechnol. 2008, 7, 125.
46. G. G. Ying, R. Kookana, T. D. Waite, Endocrine Disrupting Chemicals (EDCs) and Pharmaceuticals and Personal Care Products (PPCPs), in Reclaimed Water in Australia, Australian Water Conservation and Reuse Research Program, January 2004.
47. K. M. Lai, K. L. Johnson, M. D. Scrimshaw, J. N. Lester, Binding of Waterborne Steroid Estrogens to Solid Phases in River and Estuarine Systems, Environ. Sci. Technol. 2000, 34, 3890.
48. F. X. M. Casey, G. L. Larsen, H. Hakk, J. Simunek, Fate and Transport of 17 Beta-estradiol in Soil-Water Systems, Environ. Sci. Technol. 2003, 37, 2400.
49. J. C. Bowman, J. W. Readman, J. L. Zhou, Sorption of Natural Endocrine Disruptors, Oestrone and 17 -Oetradiol in the Aquatic Environment, Environ. Geochem. Health 2003, 25, 63.
50. B. Cheftez, T. Mualem, J. Ben-Ari, Sorption and Mobility of Pharmaceutical Compounds in Soil Irrigated with Reclaimed Wastewater, Chemosphere 2008, 73, 1335.
51. L. Yu et al., Sorption Behavior of Potential Organic Wastewater Indicators with Soils, Water Res., in press. DOI 10.1016/j.watres.2008. 11.032.
52. H. Yamamoto, H. M. Liljestrand, Y. Shimizu, M. Morita, Effects of Physical-Chemical Characteristics on the Sorption of Selected Endocrine Disruptors by Dissolved Organic Matter Surrogates, Environ. Sci. Technol. 2003, 37, 2646.
53. O. A. H. Jones, N. Voulvoulis, J. N. Lester, Partitioning Behavior of the Five Pharmaceutical Compounds to Activated Sludge and River Sediments, Arch. Environ. Contam. Toxicol. 2006, 50, 297.
54. S. A. Sassman, A. K. Sarmah, L. S. Lee, Sorption of Tylosin A,D, and A-Aldol and Degradation Of Tylosin A in Soils, Environ. Toxicol. Chem. 2007, 26, 1629.
55. S. A. Sassman, L. S. Lee, Sorption and Degradation in Soils of Veterinary Ionophore Antibiotic Monesin and Lasalocid, Environ. Toxicol. Chem. 2007, 26, 1614.
56. J. L. Bonin, M. J. Simpson, Sorption of Steroid Estrogens to Soil and Soil Constituents in Single- and Multi-Sorbate Systems, Environ. Toxicol. Chem. 2007, 26, 2604.
57. G. G. Ying, X. Y. Yu, R. S. Kookana, Biological Degradation and Triclocarbon and Triclosan in a Soil Under Aerobic and Anaerobic Conditions and Comparison with Environmental Fate Modeling, Environ. Pollut. 2007, 150, 300.
58. W. A. Arnold et al., Photochemical Fate of Pharmaceutical Compounds Discharged and Detected in Natural Waters, USGS-WRRI 104G National Grants Competition, San Diego, CA 2001-2003.
59. P. Canosa et al., Aquatic Degradation of Triclosan and Formation of Toxic Phlorophenols in the Presence of Low Concentrations of Free Chlorine, Anal. Bioanal. Chem. 2005, 383, 1119.
60. P. Mazellier, L. Meite, J. De Laat, Photodegradation of the Steroid Hormones 17 -Estradiol (E2) and 17 -Ethinylestradiol (EE2) in Dilute Aqueous Solutions, Chemosphere 2008, 73, 1216.
61. H. Yamamoto et al., Persistence and Partitioning of Eight Selected Pharmaceuticals in the Aquatic Environment: Laboratory Photolysis, Biodegradation, and Sorption Experiments, Water Res. 2009, 43, 351.
62. Y. Zhang, S. U. Geißen, C. Gal, Carbamazepine and diclofenac: Removal in Wastewater Treatment Plants and Occurrence in Water Bodies, Chemosphere 2008, 73, 1151.
63. K. Xia, C. Y. Jeong, Photodegradation of the Endocrine-Disrupting Chemical 4-Nonylphenol in Biosolids Applied to Soil, J. Environ. Qual. 2004, 33, 1568.
64. M. J. Benotti, B. J. Brownawell, Microbial Degradation of Pharmaceuticals in Estuarine and Coastal Seawater, Environ. Pollut. 2009, 157, 994.
65. P. W. Harvey, D. J. Everett, Regulation of Endocrine-Disrupting Chemicals: Critical Overview and Deficiencies in Toxicology and Risk Assessment for Human Health, Best Practice Res. Clin. Endocrinol. Metab. 2006, 20, 145.
66. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report, Washington, DC 1998.
67. I. R. Falconer, H. F. Chapman, M. R. Moore, G. Ranmuthugala, Endocrine-Disrupting Compounds: A Review of their Challenge to Sustainable and Safe Water Supply and Water Reuse, Environ. Toxicol. 2006, 21, 181.
68. M. C. Huet, OECD Activity on Endocrine Disrupters Test Guidelines Development, Ecotoxicology 2000, 9, 77.
69. K. Acosta, L. Cuvilier, B. Pedersen, European Union Regulation of Endocrine Disrupting Chemicals That Affect Reproduction: From Rachel to REACH, Roskilde University, Denmark 2005.
70. M. M. Tabb, B. Blumberg, New Models of Action for Endocrine-Disrupting Chemicals, Mol. Endocrinol. 2006, 20, 475.
71. L. Yang et al., Full Automation of Solid-Phase Microextraction/On-Fiber Derivatization for Simultaneous Determination of Endocrine-Disruption Chemicals and Steroid Hormones by Gas-Chromatography-Mass Spectrometry, Anal. Bioanal. Chem. 2006, 386, 391.
72. A. M. Peck, Analytical Methods for the Determination of Persistent Ingredients of Personal Care Products in Environmental Matrices, Anal. Bioanal. Chem. 2006, 386, 907.
73. L. Brossa, R. M. Marce, F. Borrul, E. Procurull, Determination of Endocrine Disruptors in Environmental Water Samples by Stir-Bar Sorptive Extraction-Liquid Desorption - Large Volume Injection - Gas Chromatography, Chromatographia 2005, 61, 61.
74. J. Lopez-Darias et al., Micelle-Mediated Extraction Using Nonionic Surfactant Mixtures and HPLC-UV to Determine Endocrine-Disrupting Phenols in Seawater, Anal. Bioanal. Chem. 2008, 391, 735.
75. R. Cespedes et al., Integrated Procedure for Determination of Endocrine-Disrupting Activity in Surface Waters and Sediments by Use of the Biological Technique Recombinant Yeast Assay and Chemical Analysis by LC-ESI-MS, Anal. Bioanal. Chem. 2004, 378, 697.
76. J. Chen et al., Antiandrogenic Properties Of Parabens And Other Phenolic Containing Small Molecules In Personal Care Products, Toxicol. Appl. Pharmacol. 2007, 221, 278.
77. J. Xu, L. Wu, W. Chen, A. C. Chang, Simultaneous Determination of Pharmaceuticals, Endocrine Disrupting Compounds and Hormone in Solids by Gas Chromatography-Mass Spectrometry, J. Chromatog., A 2008, 1212, 189.
78. B. Kasprzyk-Hordern, R. M. Dinsdale, A. J. Guwy, Multiresidue Methods for the Analysis of Pharmaceuticals, Personal Care Products and Illicit Drugs in Surface Water and Wastewater by Solid-Phase Extraction and Ultra Performance Liquid Chromatography Electrospray Tandem Mass Spectrometry, Anal. Bioanal. Chem. 2008, 391, 1293.
79. J. L. Zhao et al., Determination of Phenolic Endocrine Disrupting Chemicals in Surface Water of the Pearl Rivers in South China by Gas-Chromatography-Negative Chemical Ionization-Mass Spectrometry, Sci. Total Environ. 2009, 40, 962.
80. L. Viglino, K. Aboulfadl, M. Prevost, S. Sauve, Analysis of Natural and Synthetic Estrogenic Endocrine Disruptors in Environmental Wastes Using Online Preconcentration Coupled with LC-APPI-MS/MS, Talanta 2008, 76, 1088.
81. S. Zorita et al., Selective Determination of Acidic Pharmaceuticals In Wastewater Using Molecularly Imprinted Solid-Phase Extraction, Anal. Chim. Acta 2008, 626, 147.
82. L. Kantiani et al., Triclosan and Methyl-Triclosan Monitoring Study in the Northeast of Spain Using a Magnetic Particle Enzyme Immunoassay and Confirmatory Analysis By Gas Chromatography-Mass Spectrometry, J. Hydrol. 2008, 361, 1.
83. M. Roda et al., Analytical Approach for Monitoring Endocrine-Disrupting Compunds in Urban Wastewater Tretament Plants, Anal. Bioanal. Chem. 2006, 385, 742.
84. M. Terasaki, F. Shiraishi, H. Fukazawa, M. Makino, Occurrence and Estrogenity of Phenolics in Paper-Recycling Process Water: Pollutants Originating from Thermal Paper in Waste Paper, Environ. Toxicol. Chem. 2007, 26, 2356.
85. V. S. Wilson, M. C. Cardon, L. E. Gray Jr., P. C. Hartig, Competitive Binding Comparison of Endocrine-Disrupting Compounds to Recombinant Androgen Receptor from Fathead Minnow, Rainbow Trout, and Humans, Environ. Toxicol. Chem. 2007, 26, 1793.
86. E. Eriksson et al., Household Chemicals and Personal Care Products as Sources for Xenobiotic Organic Compounds in Grey Wastewater, Water SA 2003, 29, 135.
87. V. Matamoros, J. Garcia, J. M. Bayona, Organic Micropollutant Removal in a Full-Scale Surface Flow Constructed Wetland Fed With Secondary Effluent, Water Res. 2008, 42, 653.
88. J. M. Conely, S. J. Symes, M. S. Schorr, S. M. Richards, Spatial and Temporal Analysis of Pharmaceutical Concentrations in the Upper Tennesee River Basin, Chemosphere 2008, 73, 1178.
89. J. L. Santos, I. Aparicio, M. Callejon, E. Alonso, Occurrence of Pharmaceutically Active Components During the 1-Year Period in Wastewaters from Tour Wastewater Treatment Plant in Seville (Spain), J. Hazard. Mater., in press. DOI 10.1016/j.hazmat.2008.09.073.
90. J. Feitosa-Felizzola, S. Chiron, Occurrence and distribution of Selected Antibiotics in a Small Mediterranean Stream (Arc River, Southern France), J. Hydrol. 2009, 364, 50.
91. M. Gros, M. Petrovic, D. Barcelor, Wastewater Treatment Plants as a Pathway for Aquatic Contamination by Pharmaceuticals in the EBRO River Basin (North East Spain), Environ. Toxicol. Chem. 2007, 26, 1553.
92. M. Isidori et al., Influence of Alkylphenols and Trace Elements in Toxic, Genotoxic and Endocrine Disruption Activity of Wastewater Treatment Plants, Environ. Toxicol. Chem. 2007, 26, 1686.
93. J. L. Conkle, J. R. White, C. D. Metcalfe, Reduction of Pharmaceutically Active Components by a Lagoon Wetland Wastewater Treatment System in Southeast Louisiana, Chemosphere 2008, 73, 1741.
94. V. Matamoros, C. Arias, H. Brix, M. Bayona, Preliminary Screening of Small-Scale Domestic Wastewater Treatment Systems for Removal of Pharmaceutical and Personal Care Products, Water Res. 2009, 43, 55.
95. J. M. Skadsen, B. L. Rice, D. J. Meyering, The Occurrence and Fate of Pharmaceuticals, Personal Care Products and Endocrine Disrupting Compounds in a Municipal Water Use Cycle. A Case Study in the City of Ann Arbor, American Water Works Association, Denver, CO 2004.
96. M. Carballa, F. Omil, T. Ternes, J. M. Lema, Fate of Pharmaceutical and Personal Care Products (Ppcps) during Anaerobic Digestion of Sewage Sludge, Water Res. 2007, 41, 2139.
97. A. K. Mungray, P. Kumar, Degradation of Anionic Surfactants During Drying of UASBR Sludges on Sand Drying Beds, J. Environ. Manage. 2008, 88, 995.
98. K. Bester, Personal Care Compounds in the Environment: Pathways, Fate and Methods for Determination, Wiley-VCH, Weinheim 2007.
99. M. Carballa, F. Omil, J. M. Lema, Calculation Methods to Perform Mass Balances of Micropollutants in Sewage Treatment Plants. Application to Pharmaceutical and Personal Care Products (PPCP), Environ. Sci. Technol. 2007, 41, 884.
100. NACWA (The National Association of Clean Water Agencies), Pharmaceuticals and Personal Care Products in the Environment: A White Paper on Options for the Treatment Community, Washington, DC 2005.
101. A. J. Spring et al., Removal of Endocrine Disrupting Compounds Using a Membrane Bioreactor and Disinfection, J. Environ. Eng. Sci. 2007, 6, 131.
102. M. Gavrilescu, Y. Chisti, Biotechnology - A Sustainable Alternative for the Chemical Industry, Biotechnol. Adv. 2005, 23, 471.
103. A. Wick et al., Fate of Beta Blockers and Psycho-Drugs in Conventional Wastewater Treatment, Water Res., in press. DOI 0.1016/j.watres.2008.11.031.
104. J. Radjenovic, M. Petrovic, D. Barcelo, Fate and Distribution of Pharmaceuticals in Wastewater and Sewage Sludge of the Conventional Activated Sludge (CAS) and Advanced Membrane Bioreactor (MBR) Treatment, Water Res. 2009, 43, 831.
105. M. Cirja, Studies on the Behavior of Endocrine Disrupting Compounds in a Membrane Bioreactor, PhD Thesis, Institute for Biology V - Environmental Research, RWTH Aachen University, Germany 2007.
106. J. Chen et al., Degradation of environmental Endocrine Disruptor Di-2-Ethylhexyl Phthalate by a Newly Discovered Bacterium, Microbacterum sp. Strain CQ0110Y, Appl. Microbiol. Biotechnol. 2007, 74, 676.
107. E. Marco-Urrea, M. Perez-Trujillo, T. Vicent, G. Carminal, Ability of White-Rot Fungi to Remove Selected Pharmaceuticals and Identification of Degradation Products of Ibuprofen by Trametes versicolor, Chemosphere 2009, 74, 765.
108. T. Tanghe, W. Verstraete, Adsorption of Nonylphenol onto Granular Activated Carbon, Water, Air, Soil Pollut. 2001, 131, 67.
109. D. Khiari, Endocrine Disruptors, Pharmaceuticals, and Personal Care Products in Drinking Water: An Overview of AwwaRF Research to Date, Drinking Water Res. 2007, 1.
110. A. K Kumar, S. V. Mohan, P. N. Sarma, Sorptive of Endocrine-Disrupting Compound (Estriol E3) from Aqueous Phase by Batch and Column Studies: Kinetic and Mechanistic Evaluation, J. Hazard. Mater., in press. DOI10.1016/j.jhazmat.2008.08.075.
111. A. S. Mestre et al., Waste-Derived Activated Carbons for Removal of Ibuprofen from Solution: Role of Surface Chemistry and Pore Structure, Bioresour. Technol. 2009, 100, 1720.
112. J. M. Morris, S. Jin, K. Cui, Removal of Endocrine Active Components using Layered Double Hydroxide Material, Chem. Eng. J. 2008, 145, 160.
113. H. Zhou, D. W. Smith, Advanced Technologies Treatment, J. Environ. Sci. Eng. 2002, 1, 247.
114. Z. Liu, Y. Kanjo, S. Mizutani, Removal Mechanism for Endocrine Disrupting Compounds (Edcs) in Wastewater Treatment -Physical Means, Biodegradation, and Chemical Advanced Oxidation: A Review, Sci. Total Environ. 2009, 407, 731.
115. Y. Yoon et al., Removal of Endocrine Disrupting Compounds and Pharamaceuticals by Nanofiltration and Ultrafiltration Membranes, Desalination 2006, 202, 16.
116. A. M. Comerton, R. C. Andrews, D. M. Bagley, The Influence of Natural Organic Matter and Cations on the Rejection of Endocrine Disrupting and Pharmaceutically Active Components by Nanofiltration, Water Res. 2009, 327, 155.
117. D. M. Kvanli et al., Monitoring Estrogen Compounds in Wastewater Recycling Systems, Water, Air, Soil Pollut. 2008, 188, 31.
118. L. D. Nghiem, P. J. Coleman, NF/RO Filtration of the Hydrophobic Ionogenic Compound Triclosan: Transport Mechanisms and the Influence of Membrane Fouling, Sep. Purif. Technol. 2008, 62, 709.
119. J. H. Kim, P. K. Park, C. H. Lee, H. H. Kwon, Surface Modification of Nanofiltration Membranes to Improve the Removal of Organic Micro-Pollutants (Edcs And Phacs) in Drinking Water Treatment: Graft Polymerization and Cross-Linking followed by Functional Group Substitution, J. Membr. Sci. 2008, 321, 190.
120. M. M. Bobu, I. Siminiceanu, Ciprofloxacin Degradation in Water By Several Advanced Oxidation Processes, Environ. Eng. Manage. J. 2006, 5, 1039.
121. S. Esplugas, D. M. Bila, L. G. T. Krause, M. Dezott, Ozonation and Advanced Oxidation Technologies to Remove Endocrine Disrupting Chemicals (Edcs) and Pharmaceuticals and Personal Care Products (Ppcps) in Water Effluents, J. Hazard. Mater. 2007, 149, 631.
122. I. Gultekin, N. H. Ince, Synthetic Endocrine Disruptors in the Environment and Water Remediation by Advanced Oxidation Processes, J. Environ. Manage. 2007, 85, 816.
123. B. Xu et al., Photochemical Degradation of Diethyl Phthalate with UV/H2O2, J. Hazard. Mater. 2007, 139, 132.
124. M. J. Watts, K. G. Linden, Photooxidation and Subsequent Biodegradability of Recalcitrant Tri-Alkyl Phosphates TCEP and TBP in Water, Water Res. 2008, 42, 4949.
125. I. Kim, N. Yamashita, H. Tanaka, Performance of UV and UV/H2O2 Processes for the Removal of Pharmaceuticals Detected in Secondary Effluent of a Sewage Treatment Plant in Japan, J. Hazard. Mater., in press. DOI 10.1016/j.jhazmat.2008.12.020.
126. A. Kunz, P. Peralta-Zamora, N. Duran, Hydrogen Peroxide Assisted Photochemical Degradation of Ethylenediaminetetraacetic Acid, Adv. Environ. Res. 2002, 7, 197.
127. V. K. Sharma, Oxidative Transformation of Environmental Pharmaceuticals by Cl2, Clo2, O3 And Fe(VI): Kinetic Assessment, Chemosphere 2008, 73, 1379.
128. T. A. Ternes et al., Ozonation: A Tool for Removal of Pharmaceuticals, Contrast Media and Musk Fragrances from Wastewater? Water Res. 2003, 37, 1976.
129. D. Vogna et al., Advanced oxidation of the Pharmaceutical Drug Diclofenac with UV/H2O2 and Ozone, Water Res. 2004, 38, 414.
130. V. Augugliaro, M. Litter, L. Palmisano, J. Soria, The Combination of Heterogeneous Photocatalysis with Chemical and Physical Operations: A Tool for Improving the Photoprocess Performance, J. Photochem. Photobiol., C 2006, 7, 127.
131. F. Méndez-Arriaga et al., Ultrasonic Treatment of Water Contaminated with Ibuprofen, Water Res. 2008, 42, 4243.
132. M. Klavarioti, D. Mantzavinos, D. Kassinos, Removal of Residual Pharmaceuticals from Aqueous Systems by Advanced Oxidation Processes, Environ. Int. 2008, 35, 402.
133. A. G. Trovo, S. A. Santos Melo, R. F. P. Nogueira, Photodegradation of the Pharmaceuticals Amoxicillin, Bezafibrate and Paracetamol by the Photo-Fenton Process - Application to Sewage Treatment Plant Effluent, J. Photochem. Photobiol., A 2008, 198, 215.
134. V. Belgiorno et al., Review on Endocrine Disrupting-Emerging Compounds in Urban Wastewater: Occurrence Irradiation for Wastewater Reuse, Desalination 2007, 215, 166.
135. M. R. Hoffman, S. Martin, W. Choi, D. Bahnemann, Environmental Applications of Semiconductor Photocatalysis, Chem. Rev. 1995, 95, 69.
136. F. A. Caliman, C. Teodosiu, I. Balasanian, Applications of Heterogeneous Photocatalysis for Industrial Wastewater Treatment, Environ. Eng. Manage. J. 2002, 1, 187.
137. A. F. Caliman et al., Study Concerning the Influence of Oxidizing Agents on Heterogeneous Photocatalytic Degradation of Persistent Pollutants, Environ. Eng. Manage. J. 2007, 6, 483.
138. F. A. Caliman, C. Cojocaru, A. Antoniadis, I. Poulios, Optimized Photocatalytic Degradation of Alcian Blue 8 GX in the Presence Of TiO2 Suspensions, J. Hazard. Mater. 2007, 144, 265.
139. F. A. Caliman et al., Neural Networks and Genetic Algorithms Optimization of the Photocatalytic Degradation of Alcian Blue 8 GX, J. Adv. Oxidation Technol. 2008, 11, 316.
140. C. Betianu et al., Response surface Optimization of Orange II Photocatalytic Degradation in TiO2 Aqueous Suspensions, J. Chem. Technol. Biotechnol. 2008, 83, 1454.
141. T. Tanizaki, K. Kadokami, R. Shinohara, Catalytic Photodegradation of Endocrine Disrupting Chemicals using Titanium Dioxide Photosemiconductor Thin Films, Bull. Environ. Contam. Toxicol. 2002, 68, 732.
142. H. M. Coleman et al., Photocatalytic Degradation of 17 -Oestradiol on Immobilized TiO2, Appl. Catal., B 2000, 24, 1.
143. T. Nakashima, O. Yoshihisa, D. A. Tryk, A. Fujishima, Decomposition of Endocrine-Disrupting Chemicals in Water by Use of TiO2 Photocatalysts Immobilised on Polytetrafluoroetylene Mesh Sheets, J. Photochem Photobiol., A 2002, 151, 207.
144. C. Couteau, M. Jadaud, F. Peigne, L. J. M. Coiffard, Influence of pH on the Photodegradation Kinetics under UV Light of Climbazole Solutions, Analusis 2000, 28, 557.
145. J. Zhou, Q. Yue, L. Li, J. Li, Photocatalytic Degradation of Diethylstilbestrol in Water with Nano-Semiconductor Catalysts, Chem. J. Internet 2005, 7 (http://www.chemistrymag.org/cji/2005/076044ne.htm).
146. V. A. Sakkas et al., Heterogeneous Photocatalytic Degradation of the Pharmaceutical Agent Salbutamol in Aqueous Titanium Dioxide Suspensions, Appl. Catal., B 2007, 77, 135.
147. M. Addamo et al., Removal of Drugs in Aqueous Systems by Photoassisted Degradation, J. Appl. Electrochem. 2005, 35, 765.
148. S. Kaneco, H. Katsumata, T. Suzuki, K. Ohta, Titanium Dioxide Mediated Photocatalytic Degradation of Dibutyl Phthalate in Aqueous Solution-Kinetics, Mineralization and Reaction Mechanism, Chem. Eng. J. 2006, 125, 59.
149. T. Karpova, Aqueous Photocatalytic Oxidation of Steroid Estrogens, Ph.D. Thesis, Lappeenranta University of Technology, Finland 2007.
150. T. Karpova, S. Preis, J. Kallas, A. L. Barros Torres, Selective Photocatalytic Oxidation of Steroid Estrogens in the Presence of Saccharose and Ethanol as Co-Pollutant, Environ Chem. Lett. 2007, 5, 219.
151. T. Karpova, S. Preis, J. Kallas, Selective Photocatalytic Oxidation of Steroid Estrogens in Water Treatment: Urea as Co-Pollutant, J. Hazard. Mater. 2007, 146, 465.
152. T. Malygina, S. Preis, J. Kallas, The role of pH in Aqueous Photocatalytic Oxidation of B-Estradiol, Int. J. Photoenergy 2005, 7, 187.
153. T. Malygina, S. Preis, J. Kallas, Photcatalytic Oxidation and Adsorption of Natural and Synthetic Estrogens on TiO2 in Aqueous Solutions at Different pH, Chem. Ind. Environ. 2006, 1, 339.
154. S. Yurdakal et al., Photodegradation of Pharmaceutical Drugs in Aqueous TiO2 Suspensions: Mechanism and Kinetics, Catal. Today 2007, 129, 9.
155. A. Chatzitakis et al., Photocatalytic Degradation and Drug Activity Reduction of Chloramphenicol, Water Res. 2008, 42, 386.
156. X. Zhang, F. Wu, P. Chen, N. Deng, Photodegradtion of Acetaminophen in the TiO2 Suspended Solutions, J. Hazard. Mater. 2008, 157, 300.
157. Y. Lin et al., Photocatalytic Degradation of Methylparaben by TiO2: Multivariable Experimental Design and Mechanism, Appl. Catal., B DOI 10.1016/j.a.catb.2008.09.026.
158. S. A. Snyder, P. Westerhoff, Y. Yoon, D. L. Sedlak, Pharmaceuticals, Personal Care Products and Endocrine Disrupters in Water: Implications for Water Treatment, Environ. Eng. Sci. 2003, 20, 449.
159. V. K. Sharma, S. K. Mishra, A. K. Ray, Kinetic Assessment of the Potassium Ferrate(VI) Oxidation of Antibacterial Drug Sulfamethoxazole, Chemosphere 2006, 62, 128.
160. N. Nakada et al., Removal of Selected Pharmaceuticals and Personal Care Products (Ppcps) and Endocrine-Disrupting Chemicals (Edcs) during Sand Filtration and Ozonation at a Municipal Sewage Treatment Plant, Water Res. 2007, 41, 4373.
161. M. Sanchez-Polo et al., Removal of Pharmaceutical Compounds, Nitroimidazoles, from Waters by using the Ozone/Carbon System, Water Res. 2008, 42, 4163.
162. S. Lee et al., Removal of 17 -Estradiol by Powdered Activated Carbon - Microfiltration Hybrid Process: The Effect of PAC Deposition on Membrane Surfaces, J. Membr. Sci. 2008, 326, 84.
163. J. C. Flores-Escribano, Sonolysis of Pharmaceutical and Personal Care Products as an Advanced Oxidation Process for the Remediation Treatment of Wastewater Effluents, M.Sc. Thesis, University of Puerto Rico 2007.
164. P. Calza et al., Multivariate Experimental Design for the Photocatalytic Degradation of Imiprine. Determination of the Reaction Pathway and Identification of Intermediate Products, Appl. Catal., B 2008, 84, 379.
165. C. Scruggs, G. Hunter, E. Snyder, B. Long, EDCs In Wastewater: What's The Next Step? Proc. of the Water Environment Federation-WEFTEC, New Orleans LA 2004.